| 000 | 05565naa a22006377i 4500 | ||
|---|---|---|---|
| 001 | UMUN-OA-20261005-MLS-023 | ||
| 003 | local | ||
| 005 | 20261005174903.0 | ||
| 006 | m o d | ||
| 007 | cr|||||||||||| | ||
| 008 | 261005s2025 xx o u000 0 eng d | ||
| 024 | 7 |
_a10.1128/cmr.00137-24 _2doi |
|
| 035 | _a(local)EuropePMC:PMC12424361 | ||
| 040 |
_alocal _beng _clocal |
||
| 041 | 0 | _aeng | |
| 100 | 0 |
_aDonna M Wolk _eauthor. |
|
| 245 | 1 | 4 |
_aThe American Society for Microbiology's evidence-based laboratory medicine practice guidelines for the diagnosis of bloodstream infections using rapid tests: a systematic review and meta-analysis. / _cDonna M Wolk; J Scott Parrott; N Esther Babady [and others]. |
| 264 | 1 |
_a[Place of publication not identified] : _bAmerican Society for Microbiology (ASM), _c2025. |
|
| 300 | _a1 online resource (1 article). | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 500 | _aPublication type: Review article. | ||
| 500 | _aLinked open-access copy: published version. | ||
| 506 | 0 |
_aOpen access; no subscription required for the linked open-access version. _fUnrestricted online access _2star |
|
| 520 | 3 | _aSUMMARYBloodstream infections (BSIs) are a significant cause of mortality and morbidity. Rapid identification of pathogens and detection of a few resistance markers from positive blood cultures are now possible through the increased availability of commercial rapid diagnostic tests, including nucleic acid amplification tests and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. This document describes the clinical utility of rapid diagnostics performed on positive blood cultures and provides evidence-based laboratory medicine guidelines for using rapid tests to diagnose BSIs in hospitalized adult and pediatric patients. This guideline was developed for use by medical (a.k.a. clinical) microbiologists, medical laboratory professionals, infectious disease clinicians, pharmacists, hospital administrators, healthcare providers, and other stakeholders associated with BSIs. A panel of experts, including medical microbiologists and experts in systematic literature review, was assembled to formulate the Population-Intervention-Comparison-Outcome (PICO) question, review the literature, and provide recommendations for using rapid tests to diagnose BSI and improve patient outcomes. A comprehensive literature search of four electronic bibliographic databases (MEDLINE, Embase, CINAHL, and Cochrane) was conducted to identify studies with measurable outcomes. The panel followed a systematic process, which included a standardized methodology for rating the certainty of the evidence and strength of recommendations using the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach. The panel evaluated the literature to answer the question: Does using rapid diagnostic tests improve clinical outcomes in adult and pediatric patients hospitalized with a BSI? Peer-reviewed literature was available to address three outcomes, including time to targeted therapy, mortality, and length of hospital stay. In general, the quality of the evidence was low to moderate due to the paucity of controlled, randomized clinical trial studies. However, eight recommendations were made based on evidence derived from the systematic review of the published literature. To answer the PICO question, the expert committee recommended using rapid diagnostic tests combined with active communication to decrease the time to targeted therapy and length of stay (strong recommendation). While the strength of the evidence for the impact on mortality is low, the panel supports using rapid tests to impact these outcomes. A summary of the recommendations is listed in the Executive Summary, which includes a detailed description of the background, methods, evidence summary, and rationale that supports each recommendation in the full text. | |
| 540 |
_aCreative Commons Attribution. See the linked licence for the applicable terms. _uhttps://creativecommons.org/licenses/by/4.0/ |
||
| 546 | _aIn English. | ||
| 588 | 0 | _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source. | |
| 590 | _aCourse allocation: B. Sc. Medical Laboratory Science. | ||
| 650 | 4 | _aMass spectrometry | |
| 650 | 4 | _aBlood culture | |
| 650 | 4 | _aGuidelines | |
| 650 | 4 | _aDiagnostics | |
| 650 | 4 | _aBloodstream Infection | |
| 650 | 4 | _aMedical Outcomes | |
| 653 | _aB. Sc. Medical Laboratory Science | ||
| 653 | _aUMUN open access collection | ||
| 653 | _aclinical chemistry | ||
| 655 | 4 | _aReview articles. | |
| 700 | 0 |
_aJ Scott Parrott _eauthor. |
|
| 700 | 0 |
_aN Esther Babady _eauthor. |
|
| 700 | 0 |
_aA Brian Mochon _eauthor. |
|
| 700 | 0 |
_aRyan Tom _eauthor. |
|
| 700 | 0 |
_aChristen Diel _eauthor. |
|
| 700 | 0 |
_aJennifer Dien Bard _eauthor. |
|
| 700 | 0 |
_aAmanda Harrington _eauthor. |
|
| 700 | 0 |
_aD Jane Hata _eauthor. |
|
| 700 | 0 |
_aAmity L Roberts _eauthor. |
|
| 700 | 0 |
_aLindsay Boyce _eauthor. |
|
| 700 | 0 |
_aJ Kristie Johnson _eauthor. |
|
| 773 | 0 |
_tClinical microbiology reviews _gVol. 38, no. 3, (2025), pages/article e0013724 _x0893-8512 |
|
| 856 | 4 | 0 |
_uhttps://europepmc.org/articles/PMC12424361 _yRead open-access publication _zOpen access. _70 |
| 884 |
_aCourse selection and automated MARC21 enrichment from Europe PMC metadata. _g20261005 _khttps://europepmc.org/articles/PMC12424361 _qlocal |
||
| 942 | _n0 | ||
| 999 |
_c1165 _d1165 |
||